Nirat Beohar, MD, director, cardiac catheterization laboratory, medical director of the structural heart disease program, Mount Sinai Medical Center in Miami Beach, Florida, and a professor at the Columbia University Division of Cardiology, explains the financial landscape of the cath lab, what is ahead, and why cardiologists need to become more business savvy. #TCT

The business of cardiology is changing—and cath labs are working to keep up

Financial literacy is no longer optional for physicians. “If you're not financially viable, you can't function,” explained Nirat Beohar, MD. “The business education is probably just as important as learning a new procedure.”

leg veins chronic venous disease PAD peripheral artery disease

Cardiovascular health societies share new performance and quality measures for PAD management

The ACC and AHA have published updated performance and quality measures focused on the diagnosis and management of peripheral artery disease. Several other specialty societies, including SCAI and SIR, also participated in the development of this new document.

RSNA seeking new editor for cardiothoracic imaging journal

RSNA is looking for a replacement for Suhny Abbara, MD, who is now the editor-in-chief of its flagship journal.

Newsweek ranked the 50 best heart hospitals in the world

Cardiologists perform first procedure of its kind to prevent coronary obstruction after TAVR

A vulnerable heart patient required TAVR, but he faced an extremely high risk of coronary obstruction. Leaflet modification and snorkel stenting were not possible, so the group turned to a brand new treatment option: the VECTOR procedure.

Mirvat Alasnag, MD, FACP, FACC, FSCAI, FSCCT, director of catheterization laboratory and research, King Fahd Armed Forces Hospital, Jeddah-Saudi Arabia, director of TCT Middle East, and member of Society of Cardiovascular CT (SCCT) Education Committee, outlines why coronary CT angiography (CCTA) imaging will likely be a paradigm shift in cardiology, and where the gaps remain to gather more clinical evidence.

CCTA continues to transform cardiac imaging, interventional cardiology

Mirvat Alasnag, MD, spoke to Cardiovascular Business about CCTA's growing influence in cardiology. 

Video interview with ASE President David Weiner explains goals of society in 2026. #ASE

ASE president outlines need to lead on AI, sustain echo workforce

ASE President David Wiener, MD, discussed his goals for 2026 in a new video interview. "The imager who doesn't use artificial intelligence will be replaced by the imager who does,” he said.

Nick West, MD, chief medical officer, Shockwave Medical, Johnson and Johnson Meditech, explains how the company is innovating intravascular lithotripsy (IVL) therapy devices and building clinical evidence from trials for its use in a variety of calcified lesions. There are several companies developing IVL therapy, but West says Shockwave will remain the market leader because of its nearly decade long head start in the market, strong clinical evidence and has about a 10% market penetration. #IVKL

Why Shockwave Medical is so excited about the future of intravascular lithotripsy

Nick West, MD, Shockwave Medical's chief medical officer, detailed how the company is continuing to push IVL technologies forward. "We are leading the space ... we have no intention of giving up that position," he said.

Congress Money washington DC legislation coverage payment

Healthcare advocacy in 2025: American Society of Echocardiography reviews a busy year

Healthcare policies have rapidly evolved in recent years, and 2025 was no exception. From payment policies to physician shortages, ASE and other medical societies had plenty to fight for throughout the year.